Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sara Boccalini, Angela Bechini, Andrea Moscadelli, Sonia Paoli, Annamaria Schirripa & Paolo Bonanni. (2021) Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 21:5, pages 911-922.
Read now
Read now
Ruprecht Schmidt-Ott, Daniel Molnar, Anastassia Anastassopoulou, Emad Yanni, Claudia Krumm, Rafik Bekkat-Berkani, Gaël Dos Santos, Philipp Henneke, Markus Knuf, Markus Schwehm & Martin Eichner. (2020) Assessing direct and indirect effects of pediatric influenza vaccination in Germany by individual-based simulations. Human Vaccines & Immunotherapeutics 16:4, pages 836-845.
Read now
Read now
Articles from other publishers (8)
Kenneth Chan, Charlene Wong & Horace Choi. (2022) Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review. Vaccines 10:9, pages 1466.
Crossref
Crossref
Masayoshi Shinjoh, Munehiro Furuichi, Hisato Kobayashi, Yoshio Yamaguchi, Naonori Maeda, Mizuki Yaginuma, Ken Kobayashi, Taisuke Nogayama, Michiko Chiga, Mio Oshima, Yuu Kuramochi, Go Yamada, Atsushi Narabayashi, Ichiro Ookawara, Mitsuhiro Nishida, Kenichiro Tsunematsu, Isamu Kamimaki, Motoko Shimoyamada, Makoto Yoshida, Akimichi Shibata, Yuji Nakata, Nobuhiko Taguchi, Keiko Mitamura & Takao Takahashi. (2022) Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era. Vaccine 40:22, pages 3018-3026.
Crossref
Crossref
Yukako Kawahara & Hiroshi Nishiura. (2020) Exploring Influenza Vaccine Uptake and Its Determinants among University Students: A Cross-Sectional Study. Vaccines 8:1, pages 52.
Crossref
Crossref
Natsumi Shibata, Shinya Kimura, Takahiro Hoshino & Hisashi Urushihara. (2019) Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/2014 season: application of a doubly robust method to a large-scale, real-world dataset. BMC Infectious Diseases 19:1.
Crossref
Crossref
Pieter T. de Boer, Joel K. Kelso, Nilimesh Halder, Thi-Phuong-Lan Nguyen, Jocelyn Moyes, Cheryl Cohen, Ian G. Barr, Maarten J. Postma & George J. Milne. (2018) The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia. Vaccine 36:7, pages 997-1007.
Crossref
Crossref
Akira AinaiTadaki SuzukiShin-ichi TamuraHideki Hasegawa. (2017) Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate. Viral Immunology 30:6, pages 451-462.
Crossref
Crossref
Karin Hardt, Paolo Bonanni, Susan King, Jose Ignacio Santos, Mostafa El-Hodhod, Gregory D. Zimet & Scott Preiss. (2016) Vaccine strategies: Optimising outcomes. Vaccine 34:52, pages 6691-6699.
Crossref
Crossref
Masayoshi Shinjoh, Norio Sugaya, Yoshio Yamaguchi, Yuka Tomidokoro, Shinichiro Sekiguchi, Keiko Mitamura, Motoko Fujino, Hiroyuki Shiro, Osamu Komiyama, Nobuhiko Taguchi, Yuji Nakata, Naoko Yoshida, Atsushi Narabayashi, Michiko Myokai, Masanori Sato, Munehiro Furuichi, Hiroaki Baba, Hisayo Fujita, Akihiro Sato, Ichiro Ookawara, Kenichiro Tsunematsu, Makoto Yoshida, Mio Kono, Fumie Tanaka, Chiharu Kawakami, Takahisa Kimiya, Takao Takahashi & Satoshi Iwata. (2015) Effectiveness of Trivalent Inactivated Influenza Vaccine in Children Estimated by a Test-Negative Case-Control Design Study Based on Influenza Rapid Diagnostic Test Results. PLOS ONE 10:8, pages e0136539.
Crossref
Crossref